WO2023002407 - SOLUBLE PHARMACEUTICAL COMPOSITIONS COMPRISING SALTS OF DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
National phase entry is expected:
Publication Number
WO/2023/002407
Publication Date
26.01.2023
International Application No.
PCT/IB2022/056709
International Filing Date
20.07.2022
Title **
[English]
SOLUBLE PHARMACEUTICAL COMPOSITIONS COMPRISING SALTS OF DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
[French]
COMPOSITIONS PHARMACEUTIQUES SOLUBLES COMPRENANT DES SELS DE COMPOSÉ 1, 2, 4-TRIAZINE DISUBSTITUÉ
Applicants **
MINERALYS THERAPEUTICS, INC.
MITSUBISHI TANABE PHARMA CORPORATION
Inventors
MCKEAN, Robert
OHASHI, Yoshinori
OZAKI, Fuminori
OHSHIMA, Hiroki
NAGATA, Hiroomi
THIBERT, Roch
VADAS, Elizabeth
Priority Data
63/223,711
20.07.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3314 | |
| EPO | Filing, Examination, Granting | 30091 | |
| Japan | Filing, Examination, Granting | 3260 | |
| South Korea | Filing, Examination, Granting | 4378 | |
| USA | Filing, Examination, Granting | 12110 |
Total:
53,153
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed are pharmaceutical compositions comprising a salt of a compound having the formula (I): Formula (I) and one or more excipients, wherein the pharmaceutical composition avoids inducing disproportionation of the salt of the compound.[French]
L'invention concerne des compositions pharmaceutiques comprenant un sel d'un composé de formule (I) et un ou plusieurs excipients, la composition pharmaceutique évitant l'induction de la dismutation du sel du composé.